Logo image of ZONE.CA

ZONETAIL INC (ZONE.CA) Stock Analyst Earnings Estimates

TSX-V:ZONE - TSX Venture Exchange - CA98979N1006 - Common Stock - Currency: CAD

0.015  0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
ZONE.CA revenue by date.ZONE.CA revenue by date.
38.1K
-6.85%
39.3K
3.15%
36.9K
-6.11%
EBITDA
YoY % growth
ZONE.CA ebitda by date.ZONE.CA ebitda by date.
-1.985M
-8.63%
N/AN/A
EBIT
YoY % growth
ZONE.CA ebit by date.ZONE.CA ebit by date.
-1.985M
-8.22%
-1.178M
40.66%
-805.5K
31.62%
Operating Margin
ZONE.CA operating margin by date.ZONE.CA operating margin by date.
-5,209.97%-2,997.20%-2,182.93%
EPS
YoY % growth
ZONE.CA eps by date.ZONE.CA eps by date.
N/AN/AN/A

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
8.3K %
Q4 2024
Q2Q % growth
8.4K %
Q3 2024
Q2Q % growth
9.9K
17.86%
%
Q2 2024
Q2Q % growth
10.3K
-4.63%
%
Q1 2024
Q2Q % growth
8.3K
-29.06%
%
Q4 2023
Q2Q % growth
8.4K
-45.81%
%
Q3 2023
Q2Q % growth
8.4K
-35.38%
%
Q2 2023
Q2Q % growth
10.8K
157.14%
%
Q1 2023
Q2Q % growth
11.7K
120.75%
%
Q4 2022
Q2Q % growth
15.5K
-62.10%
%
Q3 2022
Q2Q % growth
13K
-23.98%
%
ZONE.CA Yearly Revenue VS EstimatesZONE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A